|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0163 | ED149747 | General Research Use | No | Female | White | 67 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0164 | ED149553 | General Research Use | No | Male | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0197 | ED148867 | General Research Use | No | Male | White | 72 | 7 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0220 | ED149586 | General Research Use | No | Female | White | 82 | 7 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_0289 | ED149839 | General Research Use | No | Male | White | 70 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0699 | ED149860 | General Research Use | No | Male | Black or African American | 61 | 7 - AREDS AMD Severity Scale Step 7 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0821 | ED149697 | General Research Use | No | Female | White | 75 | 7 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0920 | ED149756 | General Research Use | No | Male | White | 71 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0971 | ED148818 | Eye Disease Only | No | Female | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1327 | ED149456 | General Research Use | No | Female | White | 54 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1437 | ED148803 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1463 | ED148611 | General Research Use | No | Male | White | 77 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1677 | ED149732 | General Research Use | No | Female | White | 75 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1692 | ED148662 | General Research Use | No | Male | White | 85 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1833 | ED148769 | General Research Use | No | Female | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1869 | ED149516 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_1877 | ED148969 | General Research Use | No | Female | White | 85 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1889 | ED148324 | General Research Use | No | Female | White | 61 | 7 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2031 | ED149475 | General Research Use | No | Male | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2068 | ED148446 | General Research Use | No | Female | Black or African American | 68 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |